Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.
Molina-Morant D, Fernández ML, Bosch-Nicolau P, Sulleiro E, Bangher M, Salvador F, Sanchez-Montalva A, Ribeiro ALP, de Paula AMB, Eloi S, Correa-Oliveira R, Villar JC, Sosa-Estani S, Molina I. Molina-Morant D, et al. Among authors: fernandez ml. Trials. 2023 Nov 14;24(1):726. doi: 10.1186/s13063-023-07659-5. Trials. 2023. PMID: 37964376 Free PMC article. No abstract available.
[Guiding the etiological treatment of Chagas disease].
Sosa Estani S, Altcheh J, Riarte A, Freilij H, Fernandez M, Lloveras S, Pereiro A, Castellano LG, Salvatella R, Nicholls RS; Grupo de Trabajo. Sosa Estani S, et al. Medicina (B Aires). 2015;75(4):270-1. Medicina (B Aires). 2015. PMID: 26339887 Free article. Spanish. No abstract available.
Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.
Molina-Morant D, Fernández ML, Bosch-Nicolau P, Sulleiro E, Bangher M, Salvador F, Sanchez-Montalva A, Ribeiro ALP, de Paula AMB, Eloi S, Correa-Oliveira R, Villar JC, Sosa-Estani S, Molina I. Molina-Morant D, et al. Among authors: fernandez ml. Trials. 2020 Apr 15;21(1):328. doi: 10.1186/s13063-020-4226-2. Trials. 2020. PMID: 32293523 Free PMC article. Clinical Trial.
Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions".
Shikanai-Yasuda MA, Mediano MFF, Novaes CTG, Sousa AS, Sartori AMC, Santana RC, Correia D, Castro CN, Severo MMDS, Hasslocher-Moreno AM, Fernandez ML, Salvador F, Pinazo MJ, Bolella VR, Furtado PC, Corti M, Neves Pinto AY, Fica A, Molina I, Gascon J, Viñas PA, Cortez-Escalante J, Ramos AN Jr, Almeida EA. Shikanai-Yasuda MA, et al. Among authors: fernandez ml. PLoS Negl Trop Dis. 2021 Sep 30;15(9):e0009809. doi: 10.1371/journal.pntd.0009809. eCollection 2021 Sep. PLoS Negl Trop Dis. 2021. PMID: 34591866 Free PMC article.
New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.
Álvarez MG, Hernández Y, Bertocchi G, Fernández M, Lococo B, Ramírez JC, Cura C, Albizu CL, Schijman A, Abril M, Sosa-Estani S, Viotti R. Álvarez MG, et al. Antimicrob Agents Chemother. 2015 Nov 23;60(2):833-7. doi: 10.1128/AAC.00745-15. Print 2016 Feb. Antimicrob Agents Chemother. 2015. PMID: 26596935 Free PMC article.
New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up.
Álvarez MG, Ramírez JC, Bertocchi G, Fernández M, Hernández Y, Lococo B, Lopez-Albizu C, Schijman A, Cura C, Abril M, Laucella S, Tarleton RL, Natale MA, Castro Eiro M, Sosa-Estani S, Viotti R. Álvarez MG, et al. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00439-20. doi: 10.1128/AAC.00439-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32571827 Free PMC article.
Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation.
Besuschio SA, Picado A, Muñoz-Calderón A, Wehrendt DP, Fernández M, Benatar A, Diaz-Bello Z, Irurtia C, Cruz I, Ndung'u JM, Cafferata ML, Montenegro G, Sosa Estani S, Lucero RH, Alarcón de Noya B, Longhi SA, Schijman AG. Besuschio SA, et al. Among authors: fernandez m. PLoS Negl Trop Dis. 2020 Aug 14;14(8):e0008402. doi: 10.1371/journal.pntd.0008402. eCollection 2020 Aug. PLoS Negl Trop Dis. 2020. PMID: 32797041 Free PMC article.
B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi-Specific Antibody-Secreting Cells Following Successful Etiological Treatment.
Cesar G, Natale MA, Albareda MC, Alvarez MG, Lococo B, De Rissio AM, Fernandez M, Castro Eiro MD, Bertocchi G, White BE, Zabaleta F, Viotti R, Tarleton RL, Laucella SA. Cesar G, et al. J Infect Dis. 2023 May 29;227(11):1322-1332. doi: 10.1093/infdis/jiac495. J Infect Dis. 2023. PMID: 36571148 Free PMC article.
Mixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole.
Castro Eiro MD, Natale MA, Alvarez MG, Castro A, Seigelshifer D, Viotti R, Fernández M, Mazzuoccolo L, Lococo B, Bertocchi GL, Cesar G, Albareda MC, Elias MJ, Caputo MB, Gaddi E, Balbaryski J, Vigliano CA, Laucella SA. Castro Eiro MD, et al. Microbiol Spectr. 2022 Aug 31;10(4):e0135722. doi: 10.1128/spectrum.01357-22. Epub 2022 Aug 8. Microbiol Spectr. 2022. PMID: 35938810 Free PMC article.
376 results